Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 2.26B P/E - EPS this Y -22.50% Ern Qtrly Grth -
Income - Forward P/E -14.06 EPS next Y -31.80% 50D Avg Chg 14.00%
Sales - PEG 1.00 EPS past 5Y - 200D Avg Chg 39.00%
Dividend N/A Price/Book 4.13 EPS next 5Y -18.30% 52W High Chg -1.00%
Recommedations 3.00 Quick Ratio - Shares Outstanding 47.76M 52W Low Chg 214.00%
Insider Own 3.16% ROA - Shares Float - Beta -
Inst Own 105.87% ROE - Shares Shorted/Prior 4.88M/8.11M Price 47.38
Gross Margin - Profit Margin - Avg. Volume 1,708,590 Target Price 49.83
Oper. Margin - Earnings Date Aug 14 Volume 2,911,156 Change 0.36%
About DICE Therapeutics, Inc.

DICE Therapeutics, Inc., a biopharmaceutical company, builds various oral therapeutic candidates to treat chronic diseases in immunology and other therapeutic areas. Its platform DELSCAPE is designed to discover selective oral small molecules to modulate protein-protein interactions as effectively as systemic biologics. The company's lead therapeutic candidate is DC-806, an oral antagonist of the pro-inflammatory signaling molecule, interleukin-17 (IL-17) that is a validated drug target implicated in a various immunology indications. It also develops DC-853, an oral IL-17 antagonist. In addition, the company is developing oral therapeutic candidates targeting alpha 4 beta 7 integrin for the treatment of inflammatory bowel diseases, as well as targeting alpha V beta 1/ alpha V beta 6 integrin for the treatment of idiopathic pulmonary fibrosis. Further, it focuses on programmed death-ligand 1 program, an immuno-oncology targeting antibody therapeutics. The company was founded in 2013 and is headquartered in South San Francisco, California.

DICE Chatroom

User Image stockilluminati Posted - 6 months ago

$DICE https://clinicaltrials.gov/study/NCT05994807 - trial update posted here!

User Image stockilluminati Posted - 6 months ago

$DICE https://www.stockilluminati.com/dice/display.php?url=https://clinicaltrials.gov/study/NCT05994807 - trial update posted here!

User Image tickeron Posted - 7 months ago

$ATOM vs. $DICE: what will be the best investment? #Atomera https://srnk.us/go/4856108

User Image tickeron Posted - 7 months ago

$ATOM vs. $DICE: what will be the best investment? #Atomera https://srnk.us/go/4852991

User Image tickeron Posted - 08/29/23

$ATOM vs. $DICE: what will be the best investment? #Atomera https://srnk.us/go/4847705

User Image tickeron Posted - 08/27/23

$ATOM vs. $DICE: which stock is the best to buy? #Atomera https://srnk.us/go/4846224

User Image tickeron Posted - 8 months ago

$BR vs. $DICE: what is the best stock to add to your portfolio? #BroadridgeFinancialSolutions https://srnk.us/go/4841749

User Image tickeron Posted - 8 months ago

$ATOM vs. $DICE: what will be the best investment? #Atomera https://srnk.us/go/4840908

User Image risenhoover Posted - 8 months ago

$DICE / DICE Therapeutics files form 15-12G https://fintel.io/sf/us/dice?utm_source=stocktwits.com&utm_medium=referral&utm_campaign=filing

User Image cctranscripts Posted - 8 months ago

Securities registration termination [Section 12(g)] https://www.conferencecalltranscripts.org/summary/?id=12473852 $DICE

User Image Quantisnow Posted - 8 months ago

$DICE 📜 SEC Form 15-12G filed by DICE Therapeutics Inc. https://quantisnow.com/i/4920041?utm_source=stocktwits 45 seconds delayed.

User Image tickeron Posted - 8 months ago

$ATOM vs. $DICE: what is the best stock to add to your portfolio? #Atomera https://srnk.us/go/4839035

User Image stockilluminati Posted - 8 months ago

$DICE https://www.stockilluminati.com/dice/display.php?url=http://classic.clinicaltrials.gov/ct2/show/NCT05994807 - trial update posted here!

User Image macroaxis Posted - 8 months ago

$NERV - Investment perspective on Minerva Neurosciences vs. Dice Molecules ( $DICE ) in September 2023. Next fiscal quarter end is on 30th of September 2023 https://www.macroaxis.com/competition/NERV/DICE/Minerva-vs-Dice #portfolio_prospective #better_portfolio #diversify

User Image ChartMill Posted - 8 months ago

$NVO, $DICE and $BLDR. Strong technicals stocks and near a new high. https://www.chartmill.com/stock/stock-screener?sid=16&f=p_pg10,v1_50b500,s_str,s_nnh,exch_us&v=3&timeframe=DAILY&type=CANDLES&months=0.05&width=720&cl=F&o1=3&o2=3&o3=1&op1=200,16711680&op2=50,255&utm_source=Strong_Stocks_near_New_High&utm_medium=stocktwits&utm_campaign=screen

User Image cctranscripts Posted - 8 months ago

Notice of Effectiveness https://www.conferencecalltranscripts.org/summary/?id=12446467 $DICE

User Image stockilluminati Posted - 8 months ago

$DICE https://www.stockilluminati.com/dice/filings.php - DICE Therapeutics, Inc. - Common Stock files form EFFECT today, check out the details.

User Image Quantisnow Posted - 8 months ago

$DICE 📜 SEC Form EFFECT filed by DICE Therapeutics Inc. https://quantisnow.com/i/4881344?utm_source=stocktwits 45 seconds delayed.

User Image stockilluminati Posted - 8 months ago

$DICE DICE is scheduled to release earnings after close with EPS estimate -0.661900 and revenue estimate $0 check https://stockilluminati.com/earnings.html

User Image MarketBeat Posted - 8 months ago

DICE Therapeutics's neutral rating reiterated at HC Wainwright. $48.00 PT. www.marketbeat.com/stocks/NASDAQ/DICE/price-target/ $DICE

User Image cctranscripts Posted - 8 months ago

RA Capital Healthcare Fund, L.P. just issued a filing suggesting it has sold all of its DICE Th https://www.conferencecalltranscripts.org/summary/?id=12439079 $DICE

User Image Quantisnow Posted - 8 months ago

$DICE New live insights: 1. 📜 SEC Form SC 13D/A filed by DICE Therapeutics Inc. (Amendment) https://quantisnow.com/i/4872367?utm_source=stocktwits 2. 📜 SEC Form 4 filed by Ra Capital Management, L.P. https://quantisnow.com/i/4872377?utm_source=stocktwits #healthcare

User Image Quantisnow Posted - 8 months ago

$DICE New insights just appeared: 1. 📜 SEC Form 4: Scheller Richard H returned 8,427 shares to the company, closing all direct ownership in the company https://quantisnow.com/i/4871751?utm_source=stocktwits 2. 📜 SEC Form 4: Robertson Scott M. returned 198,000 shares to the company, closing all direct ownership in the company https://quantisnow.com/i/4871866?utm_source=stocktwits 3. 📜 SEC Form 4: Scopa James Paul returned 40,921 shares to the company, closing all direct ownership in the company https://quantisnow.com/i/4871907?utm_source=stocktwits 4. 📜 SEC Form 4 filed by Simson Jake https://quantisnow.com/i/4871963?utm_source=stocktwits 5. 📜 SEC Form 4: Tetlow Sharon returned 49,841 shares to the company, closing all direct ownership in the company https://quantisnow.com/i/4871997?utm_source=stocktwits #healthcare

User Image Quantisnow Posted - 8 months ago

$DICE 📜 SEC Form 4: Timothy Lu returned 152,285 shares to the company, closing all direct ownership in the company https://quantisnow.com/i/4871715?utm_source=stocktwits 45 seconds delayed.

User Image Quantisnow Posted - 8 months ago

$DICE 📜 SEC Form 4 filed by Bowers Lisa https://quantisnow.com/i/4871531?utm_source=stocktwits 45 seconds delayed.

User Image risenhoover Posted - 8 months ago

$DICE / DICE Therapeutics files form 8-K - UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 9, 2023 DICE THERAPEUTICS, https://fintel.io/sf/us/dice?utm_source=stocktwits.com&utm_medium=referral&utm_campaign=filing

User Image risenhoover Posted - 8 months ago

$DICE / DICE Therapeutics files form SC 14D9/A https://fintel.io/sf/us/dice?utm_source=stocktwits.com&utm_medium=referral&utm_campaign=filing

User Image risenhoover Posted - 8 months ago

$DICE / DICE Therapeutics files form POSASR https://fintel.io/sf/us/dice?utm_source=stocktwits.com&utm_medium=referral&utm_campaign=filing

User Image risenhoover Posted - 8 months ago

$DICE / DICE Therapeutics files form S-8 POS https://fintel.io/sf/us/dice?utm_source=stocktwits.com&utm_medium=referral&utm_campaign=filing

User Image risenhoover Posted - 8 months ago

$DICE / DICE Therapeutics files form S-8 POS https://fintel.io/sf/us/dice?utm_source=stocktwits.com&utm_medium=referral&utm_campaign=filing

Analyst Ratings
HC Wainwright & Co. Neutral Aug 9, 23
Needham Hold Jun 26, 23
Canaccord Genuity Hold Jun 21, 23
HC Wainwright & Co. Neutral Jun 21, 23
Wells Fargo Equal-Weight Jun 20, 23
Cantor Fitzgerald Neutral Jun 20, 23
Canaccord Genuity Hold Jun 20, 23
Wells Fargo Equal-Weight May 24, 23
Canaccord Genuity Buy May 22, 23
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Northpond Ventures GP, LLC 10% Owner 10% Owner Jun 22 Sell 46.5 2,492,871 115,918,502 166,293 06/23/23
Jacobsen John R. CSO CSO Jun 01 Sell 30.78 18,750 577,125 147,497 06/02/23
SCHELLER RICHARD H Director Director May 05 Sell 38.5056 84,097 3,238,205 8,427 05/09/23
Jacobsen John R. CSO CSO Apr 18 Sell 30.0834 16,392 493,127 166,247 04/19/23
RA CAPITAL MANAGEMENT, L.P. Director Director Mar 28 Buy 29.12 509,145 14,826,302 7,070,205 03/30/23
Northpond Ventures GP, LLC 10% Owner 10% Owner Sep 20 Buy 17 235,000 3,995,000 3,292,871 09/20/21